TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06633562

A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults

Cause of deathRegulatory or ethics Automatic label, confidence 0.9, unverified. How labels are made.
“The trial was terminated early due to regulatory constraints preventing the continuation of study conduct.”

The sponsor’s own words in the registry.

Life of this trial

202420252026Registered2024-10-07Started2025-02-28Stopped2025-12-22

Vital statistics

Status
Terminated
Phase
Phase 1
Sponsor
Lohocla Research Corporation
Sponsor type
Industry
Conditions
Healthy; Safety Evaluation of Escalating Doses; Tolerability
Interventions
Nezavist SDD; Placebo
Participants
29
Sites
1
Countries
United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.